K Health, The Leading AI Primary Care Platform, Raises $50 Million Equity Funding Round
Summary
Led by Claure Group, The New Investment Seeks to Expand Clinical Artificial Intelligence in Personalized Primary Care within Leading Health SystemsNEW YORK, July 1, 2024-- K Health, the leading AI Primary Care platform, announced today that it has raised $50M in funding led by Claure Group, with participation from investors including Pablo Legorreta (founder and CEO of Royalty Pharma), and existing investors Mangrove Capital Partners, Valor Equity Partners, and Atreides Management, LP. K Health solves the need to make primary care visits highly personalized by giving doctors AI super powers that enable them to practice at the top of their license. When partnered with leading health systems like Cedars-Sinai, this model creates significant benefits to access, clinical outcomes, and patient experience. The company has been developing AI technology for over seven years and employs proprietary data sets to highly personalize clinical care for patients. K Healths platform includes a medical chat and AI predictive models based on large datasets to help physicians optimize diagnosis and treatment, and focus on patient care.